
### [NCIT:C7258](http://purl.obolibrary.org/obo/NCIT_C7258)
**Label:** Nodular Lymphocyte Predominant Hodgkin Lymphoma

**Subclasses:** [NCIT:C5070](http://purl.obolibrary.org/obo/NCIT_C5070) (Stage II Nodular Lymphocyte Predominant Hodgkin Lymphoma), [NCIT:C7261](http://purl.obolibrary.org/obo/NCIT_C7261) (Stage IV Nodular Lymphocyte Predominant Hodgkin Lymphoma), [NCIT:C7260](http://purl.obolibrary.org/obo/NCIT_C7260) (Refractory Nodular Lymphocyte Predominant Hodgkin Lymphoma), [NCIT:C7942](http://purl.obolibrary.org/obo/NCIT_C7942) (Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma), [NCIT:C7259](http://purl.obolibrary.org/obo/NCIT_C7259) (Recurrent Nodular Lymphocyte Predominant Hodgkin Lymphoma), [NCIT:C8060](http://purl.obolibrary.org/obo/NCIT_C8060) (Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma), [NCIT:C5634](http://purl.obolibrary.org/obo/NCIT_C5634) (Stage I Nodular Lymphocyte Predominant Hodgkin Lymphoma), [NCIT:C7262](http://purl.obolibrary.org/obo/NCIT_C7262) (Stage III Nodular Lymphocyte Predominant Hodgkin Lymphoma), 

**Class expressions from DL-Learner:**

- Thing 53.84%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 37.53%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40287](http://purl.obolibrary.org/obo/NCIT_C40287) (Vulvar Warty Carcinoma))) 37.53%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40286](http://purl.obolibrary.org/obo/NCIT_C40286) (Vulvar Basaloid Carcinoma))) 37.53%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40284](http://purl.obolibrary.org/obo/NCIT_C40284) (Vulvar Keratinizing Squamous Cell Carcinoma))) 37.53%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40275](http://purl.obolibrary.org/obo/NCIT_C40275) (Benign Vaginal Mixed Epithelial and Mesenchymal Neoplasm))) 37.53%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40272](http://purl.obolibrary.org/obo/NCIT_C40272) (Vaginal Undifferentiated Sarcoma))) 37.53%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40271](http://purl.obolibrary.org/obo/NCIT_C40271) (Low Grade Endometrioid Stromal Sarcoma of the Vagina))) 37.53%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C4027](http://purl.obolibrary.org/obo/NCIT_C4027) (Paget Disease of the Vulva))) 37.53%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40264](http://purl.obolibrary.org/obo/NCIT_C40264) (Vaginal Undifferentiated Carcinoma))) 37.53%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40263](http://purl.obolibrary.org/obo/NCIT_C40263) (Vaginal Small Cell Carcinoma))) 37.53%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40261](http://purl.obolibrary.org/obo/NCIT_C40261) (Vaginal Adenoid Cystic Carcinoma))) 37.53%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40260](http://purl.obolibrary.org/obo/NCIT_C40260) (Vaginal Adenosquamous Carcinoma))) 37.53%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C4026](http://purl.obolibrary.org/obo/NCIT_C4026) (Ovarian Mucinous Cystadenocarcinoma))) 37.53%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40259](http://purl.obolibrary.org/obo/NCIT_C40259) (Vaginal Villous Adenoma))) 37.53%


